Eltanexor
| CAS No. | 1642300-52-4 |
|---|---|
| MDL No. | N/A |
| MF | C17H10F6N6O |
| MW | 428.29 |
| InChI Key | JFBAVWVBLRIWHM-AWNIVKPZSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Eltanexor is a triazole compound featuring a 1H-1,2,4-triazole ring substituted at positions 1 and 3 with (1E)-3-amino-3-oxo-2-(pyrimidin-5-yl)prop-1-en-1-yl and 3,5-bis(trifluoromethyl)phenyl groups, respectively. It is a second-generation exportin 1 inhibitor in phase II clinical trials for higher relapsed/refractory myelodysplastic neoplasms. It functions as an exportin 1 inhibitor, antineoplastic agent, and apoptosis inducer. It belongs to the classes of (trifluoromethyl)benzenes, triazoles, pyrimidines, enamides, and primary carboxamides.
| CAS No. | 1642300-52-4 |
|---|---|
| Product Name | Eltanexor |
Associated Conditions
neoplasm·acute myeloid leukemia·myeloid leukemia·myelodysplastic syndrome
* The information provided here is compiled from public sources and is for reference only.